The University of Florida College of Medicine – Jacksonville is the largest of the three University of Florida Health Science Center Jacksonville colleges — medicine, nursing and pharmacy. The college's 16 clinical science departments house more than 440 faculty members and 380 residents and fellows.

During the past decade, University of Florida conducted 165 clinical trials. In the 10-year time frame, 165 clinical trials started and 79 clinical trials were completed, i.e. on average, 47.9% percent of trials that started reached the finish line to date. In the past 5 years, 84 clinical trials started and 46 clinical trials were completed. i.e. 54.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Florida" #1 sponsor was "University of Florida" with 70 trials, followed by "Janssen Research & Development, LLC" with 10 trials sponsored, "Abbott Medical Devices" with 8 trials sponsored, "Bayer" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 157 different institutions and companies that sponsored additional 126 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Florida" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator and "National Institutes of Health (NIH)" with 5 trials as a collaborator. Other collaborators include 208 different institutions and companies that were collaborators in the rest 172 trials.

According to Clinical.Site data, the most researched conditions in "University of Florida" are "Coronary Artery Disease" (32 trials), "Heart Failure" (14 trials), "Sepsis" (7 trials), "Atrial Fibrillation" (5 trials) and "Pulmonary Arterial Hypertension" (5 trials). Many other conditions were trialed in "University of Florida" in a lesser frequency.

Most popular intervention types in "University of Florida" are "Drug" (158 trials), "Device" (42 trials), "Other" (40 trials), "Biological" (16 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (56 trials), "Prasugrel" (8 trials), "Ticagrelor" (8 trials), "Clopidogrel" (7 trials) and "placebo" (7 trials). Other intervention names were less common.

The vast majority of trials in "University of Florida" are 237 trials for "All" genders, 11 trials for "Male" genders and 10 trials for "Female" genders.

Currently, there are 85 active trials in "University of Florida". 1 are not yet recruiting, 59 are recruiting, 24 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 131 completed trials in University of Florida, 1 suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in University of Florida, 13 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 35 trials, and there were also 51 trials that are defined as “Not Applicable".

University of Florida has several departments that took part in Clinical trials: "Univ of Florida Health Science Ctr / Pediatrics" - 30 trials, "UF Health Jacksonville-Gastroenterology Emerson" - 10 trials, "University of Florida Pediatrics Genetics-Site Number:840121" - 4 trials, "University of Florida Neuroscience Institute" - 4 trials, "University of Florida, Rheumatology at ACC" - 2 trials, "Hematology/Oncology Associates, PA" - 2 trials, "University of Florida/Jacksonville Faculty Clinic" - 2 trials, "Univ. of Florida, Div. of Infectious Diseases CRS" - 2 trials, "UF Health Orthopaedic Surgery Clinic" - 2 trials